Nomura Holdings
PHAT icon

Nomura Holdings’s Phathom Pharmaceuticals PHAT Stock Holding History

Nomura Holdings’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$533K Buy
+49,100
New +$560K ﹤0.01% 1498

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Nomura Holdings's PHAT Position: Q2 2026 in Review

Nomura Holdings opened a new position in Phathom Pharmaceuticals (PHAT) in Q2 2026: 40,000 shares worth $434K. The stake represents ﹤0.01% of the portfolio and ranks #1543 among its holdings.

162 funds tracked by Wall St. Rank hold PHAT as of Q2 2026.

  • Nomura Holdings held 40,000 shares of Phathom Pharmaceuticals worth $434K as of Q2 2026.
  • Phathom Pharmaceuticals was a new Nomura Holdings position in Q2 2026.
  • Phathom Pharmaceuticals made up ﹤0.01% of Nomura Holdings's portfolio in Q2 2026, its #1543 holding.
  • 162 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.